Dana-Farber Cancer Institute Merrimack Valley — Methuen, Massachusetts

Dana-Farber Cancer Institute Merrimack Valley is a clinical research site located in Methuen, Massachusetts, United States 01844.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

Dana-Farber Cancer Institute Merrimack Valley has participated in 6 clinical trials with 5 currently active.

Therapeutic areas: Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer, Breast Cancer.

Sponsors: Mirati Therapeutics Inc., Stemline Therapeutics, Inc., Omar Nadeem, MD.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Methuen

Browse all research sites in Massachusetts · View every site in Methuen

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-Farber Cancer Institute Merrimack Valley?

Dana-Farber Cancer Institute Merrimack Valley has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-Farber Cancer Institute Merrimack Valley conducted?

Dana-Farber Cancer Institute Merrimack Valley has 6 clinical trials on record, with 5 currently active. Their work covers Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer, Breast Cancer.

Is Dana-Farber Cancer Institute Merrimack Valley accredited by Crixeo Clinical Trials?

Dana-Farber Cancer Institute Merrimack Valley has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana-Farber Cancer Institute Merrimack Valley?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.